Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

PCSA — Processa Pharmaceuticals, Inc. Dilution Risk Tracker

Track PCSA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PCSA — Get alerts when the score changes →

As of October 13, 2026, Processa Pharmaceuticals, Inc. (PCSA) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Processa Pharmaceuticals, Inc. has a market capitalization of $5.31M, 2.79M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 303.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
17
⚠️ Warrant Exposure
50
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 35%
💰 Capital Raise model 55%
• Critical: only 0.2 months cash remaining
🔄 Reverse Split model est. 15%
• Only 0 months cash — financial pressure
📜 Warrant Exercise model 15%
• Warrant overhang: 10.9% of shares outstanding
🔔 Track PCSA — Get forecast alerts →

Market Data

Market Cap$5.31M
Shares Outstanding2.79M
Float2.48M
Cash$196.3K
Debt$257.5K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding2.79MVerified float table or market cache
Public Float2.48MVerified float table or market cache
Market Cap$5.31MMarket data cache
Cash Runway0.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants303.7KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, FORM 4 4, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 100.0% shares (2025Q4 vs prior)
1 institutional holders · 378 shares
#1 BANK OF AMERICA CORP /DE/ 378 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.1K
Days to Cover1.0
% of Float0.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-03-20
xbrl XBRL CONVERTIBLE 2021-03-25
Form 4 INSIDER TRANSACTION 2026-08-08
4 INSIDER TRANSACTION 2026-07-30
Form 4 INSIDER TRANSACTION 2026-07-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PCSA Dilution Snapshot

Processa Pharmaceuticals, Inc. (PCSA) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PCSA's DilutionScore has held steady at 65/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202665/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PCSA shares outstanding have increased 3.0% from 2.66M (Mar 2026) to 2.74M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 09, 20262.74M2.48M▲ 3.09%
May 03, 20262.66M2.40M▼ 0.11%
Apr 27, 20262.66M2.41M▼ 0.78%
Apr 20, 20262.66M2.42M▼ 0.31%
Apr 07, 20262.66M2.43M▼ 0.10%
Mar 27, 20262.66M2.43M▲ 1.64%
Mar 26, 20262.66M2.40M▲ 17.40%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PCSA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PCSA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PCSA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PCSA
PCSA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.